1. Anawalt, B.D., Bebb, R.A., Matsumoto, A.M., Groome, N.P., Illingworth, P.J., McNeilly, A.S. and Bremner, W.J. (1996) Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J. Clin. Endocrinol. Metab., 81, 3341–3345.
2. Anawalt, B.D., Herbst, K.L., Matsumoto, A.M., Mulders, T.M., Coelingh-Bennink, H.J. and Bremner, W.J. (2000) Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression. Fertil. Steril., 74, 707–714.
3. Anderson, F.H., Francis, R.M., Peaston, R.T. and Wastell, H.J. (1997) Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption. J. Bone Min. Res., 12, 472–478.
4. Anderson, R.A. and Wu, F.C.W. (1996) Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once-weekly administration of testosterone enanthate. J. Clin. Endocrinol. Metab., 81, 896–901.
5. Anderson, R.A. and Sharpe, R.M. (2000) Regulation of inhibin production in the human male and its clinical applications. Int. J. Androl., 23, 136–144.